Content about Branded

May 17, 2012

Wolters Kluwer Health has introduced what it called the first mobile application for the Nursing Drug Handbook, the company said Thursday.

AMBLER, Pa. — Wolters Kluwer Health has introduced what it called the first mobile application for the Nursing Drug Handbook, the company said Thursday.

Published by Lippincott Williams & Wilkins, the app is available for Apple and Android devices and is a mobile version of the popular reference for nurses that includes weekly updates.

May 16, 2012

Medication nonadherence costs the U.S. healthcare system about $290 billion per year, according to New England Healthcare Institute. That big and scary number — the kind whose sheer enormity can make one’s eyes glaze over — is now even bigger.


Medication nonadherence costs the U.S. healthcare system about $290 billion per year, according to New England Healthcare Institute. That big and scary number — the kind whose sheer enormity can make one’s eyes glaze over — is now even bigger.


May 16, 2012

Watson has announced its intention to acquire Actavis, the company said. Following news reports that the U.S.-based generic drug maker would acquire Switzerland-based Actavis, Watson announced that it would buy the latter for $5.6 billion.

SUPPLIER NEWS — Watson has announced its intention to acquire Actavis, the company said. Following news reports that the U.S.-based generic drug maker would acquire Switzerland-based Actavis, Watson announced that it would buy the latter for $5.6 billion. News media had reported that the deal would be worth $5.9 billion, while there had been estimates in March that Watson would pay up to $7.3 billion. 


May 16, 2012

An experimental kidney cancer drug made by Pfizer didn't extend the time in which patients survived without their disease worsening when compared with a competing drug, according to results of a late-stage clinical trial released Wednesday.

NEW YORK — An experimental kidney cancer drug made by Pfizer didn't extend the time in which patients survived without their disease worsening when compared with a competing drug, according to results of a late-stage clinical trial released Wednesday.

May 15, 2012

The head of drug maker AstraZeneca will retire next month, the company said.

LONDON — The head of drug maker AstraZeneca will retire next month, the company said.

The Anglo-Swedish drug manufacturer announced the planned retirement of CEO and board member David Brennan, effective June 1.

Executive director and CFO Simon Lowth will act as interim CEO following Brennan's departure, until a new CEO can be found, while VP group finance Julie Brown will become interim CFO.

May 15, 2012

GlaxoSmithKline is acquiring the remainder of a privately owned research and development company, GSK said Tuesday.

LONDON — GlaxoSmithKline is acquiring the remainder of a privately owned research and development company, GSK said Tuesday.

The British drug maker announced that it would buy the shares of Cellzome it doesn't already own for $99 million. Cellzome has labs in the United Kingdom and Germany, and will become part of GSK's research and development organization. The company, of which GSK currently owns 19.98%, develops technologies for profiling compounds in cells and patient samples.

May 15, 2012

A former football coach is joining an effort to educate men about the risks of a deadly form of skin cancer.

NEW YORK — A former football coach is joining an effort to educate men about the risks of a deadly form of skin cancer.

Former National Football League Pittsburgh Steelers coach Bill Cowher will work with Melanoma Exposed, an educational campaign run by the Melanoma International Foundation, Melanoma Research Alliance, Melanoma Research Foundation and the Skin Cancer Foundation, with sponsorship from drug maker Bristol-Myers Squibb, the organizations announced Tuesday.

May 15, 2012

Pfizer apparently is relenting on its attempt to drive sales of its top cholesterol drug as several new generic versions look set to enter the market, according to published reports.

NEW YORK — Pfizer apparently is relenting on its attempt to drive sales of its top cholesterol drug as several new generic versions look set to enter the market, according to published reports.

The Associated Press reported that Pfizer was "quietly" giving up on the drug Lipitor (atorvastatin) after an $87 million campaign to continue marketing the drug despite generic competition.

May 15, 2012

Walgreens on Tuesday infused greater value into its Prescription Savings Club program, which now offers discounts on more than 8,000 brand-name and generic prescriptions, thanks to the inclusion of more than 700 "value-priced" generics, which retail as low as $12 for a 90-day supply.

DEERFIELD Ill. — Walgreens on Tuesday infused greater value into its Prescription Savings Club program, which now offers discounts on more than 8,000 brand-name and generic prescriptions, thanks to the inclusion of more than 700 "value-priced" generics, which retail as low as $12 for a 90-day supply.

May 14, 2012

A Food and Drug Administration expert panel has recommended approval of a drug made by Gilead Sciences for treating HIV, the drug maker said Friday.

FOSTER CITY, Calif. — Gilead Sciences scored a second favorable Food and Drug Administration expert panel vote as the FDA's Antiviral Drugs Advisory Committee recommended on Friday that the regulatory agency approve an experimental drug designed to treat HIV.

May 14, 2012

Giant Food Stores collected nearly 3 tons of unused medications during a nationwide medication take-back day last month, the chain said.

CARLISLE, Pa. — Giant Food Stores collected nearly 3 tons of unused medications during a nationwide medication take-back day last month, the chain said.

Giant, owned by Dutch supermarket operator Ahold, said it and its Martin's Food Markets banner collected 5,843 lbs of unwanted and expired medications at 43 of its stores during the April 28 take-back event, doubling the amount collected last year.

May 14, 2012

A company that makes an emergency treatment for severe allergic reactions is marking the 15th annual Food Allergy Awareness Week.

BASKING RIDGE, N.J. — A company that makes an emergency treatment for severe allergic reactions is marking the 15th annual Food Allergy Awareness Week.

Mylan Specialty, a division of drug maker Mylan, said it would support various initiatives to raise awareness of life-threatening food allergies during the special week, which started Sunday and ends Saturday. Mylan Specialty is the maker of EpiPen (epinephrine), used to treat anaphylaxis, a severe allergic reaction that can occur quickly and without warning.

May 11, 2012

Biotech drug maker Amgen has joined the list of companies offering testimony at a Food and Drug Administration hearing on biosimilars Friday.

THOUSAND OAKS, Calif. — Biotech drug maker Amgen has joined the list of companies offering testimony at a Food and Drug Administration hearing on biosimilars Friday.

May 11, 2012

An expert panel at the Food and Drug Administration has recommended that the agency approve a drug made by Gilead Sciences for lowering the risk of infection by the virus that causes AIDS.

FOSTER CITY, Calif. — An expert panel at the Food and Drug Administration has recommended that the agency approve a drug made by Gilead Sciences for lowering the risk of infection by the virus that causes AIDS.

May 11, 2012

GlaxoSmithKline is moving forward with its acquisition of Human Genome Sciences.

LONDON — GlaxoSmithKline is moving forward with its acquisition of Human Genome Sciences.

The drug maker said Thursday that it has commenced its previously announced tender offer to acquire all of the outstanding shares of Human Genome Sciences for $13.00 per share in cash, a premium of 81% to HGS's closing share price of $7.17 per share on April 18, the last trading day before HGS publicly disclosed GSK's private offer.

May 10, 2012

A Food and Drug Administration expert panel has recommended approval for a drug made by Pfizer for treating rheumatoid arthritis.

NEW YORK — A Food and Drug Administration expert panel has recommended approval for a drug made by Pfizer for treating rheumatoid arthritis.

May 9, 2012

Kerr Drug announced the launch of its Healthy Pet program, offering a full range of pet medications that customers can order on the chain's website and have delivered to their homes, the regional retail pharmacy chain said Wednesday.

RALEIGH, N.C. — Kerr Drug announced the launch of its Healthy Pet program, offering a full range of pet medications that customers can order online on the chain's website and have delivered to their homes, the regional retail pharmacy chain said Wednesday.

May 9, 2012

Seattle Genetics and Takeda's cancer drug subsidiary have started a late-stage clinical trial for a lymphoma drug, the companies said Wednesday.

BOTHELL, Wash. — Seattle Genetics and Takeda's cancer drug subsidiary have started a late-stage clinical trial for a lymphoma drug, the companies said Wednesday.

Seattle Genetics and Millennium announced the start of a phase-3 trial of Adcetris (brentuximab vedotin) in patients relapsed cutaneous T-cell lymphoma that expresses the CD30 cell membrane protein. The study will enroll more than 120 patients who will be divided into two groups, one of which will receive Adcetris and another that will receive methotrexate or bexarotene.

May 8, 2012

An organization that promotes efforts to stop prescription drug abuse announced Tuesday the release of a mobile app that directs users to places where they can safely get rid of unwanted and unused medications.

WASHINGTON — An organization that promotes efforts to stop prescription drug abuse announced Tuesday the release of a mobile app that directs users to places where they can safely get rid of unwanted and unused medications.

The American Medicine Chest Challenge said the AMCC Rx Drop app, sponsored by the Generic Pharmaceutical Association, links to the AMCC's directory of local, county and state law enforcement-sponsored permanent collection sites around the country. The app is available for Apple and Android devices.

May 8, 2012

A generic version of a schizophrenia drug made by Otsuka Holdings and Bristol-Myers Squibb can't be launched until April 2015, according to published reports.

NEW YORK — A generic version of a schizophrenia drug made by Otsuka Holdings and Bristol-Myers Squibb can't be launched until April 2015, according to published reports.

Bloomberg reported that the U.S. Court of Appeals for the Federal Circuit upheld the validity of patents covering Abilify (aripiprazole) in the two companies' lawsuit against Teva Pharmaceutical Industries and Apotex.

According to IMS Health, Abilify was the fourth top-selling drug in the United States in 2011, with sales of $5.2 billion.

May 8, 2012

University of British Columbia researchers may have found a way to develop universal flu vaccines and eliminate the need for seasonal flu vaccinations, university officials announced Tuesday.

VANCOUVER, British Columbia — University of British Columbia researchers may have found a way to develop universal flu vaccines and eliminate the need for seasonal flu vaccinations, university officials announced Tuesday.

May 8, 2012

Consumption of probiotics is associated with a reduced risk of antibiotic-associated diarrhea, a common adverse effect of antibiotic use, according to a review and meta-analysis of previous studies published in the May 9 issue of JAMA, the Journal of the American Medical Association.

CHICAGO — Consumption of probiotics is associated with a reduced risk of antibiotic-associated diarrhea, a common adverse effect of antibiotic use, according to a review and meta-analysis of previous studies published in the May 9 issue of JAMA, the Journal of the American Medical Association.

May 7, 2012

Pharmaceutical wholesaler H. D. Smith will act as the exclusive supplier of various healthcare products for a buying group that serves independent pharmacies, the company said Monday.

SPRINGFIELD, Ill. — Pharmaceutical wholesaler H. D. Smith will act as the exclusive supplier of various healthcare products for a buying group that serves independent pharmacies, the company said Monday.

May 7, 2012

Drug maker Purdue Pharma has introduced a new educational resource for healthcare professionals designed to curb the abuse of prescription drugs, the company said Monday.

STAMFORD, Conn. — Drug maker Purdue Pharma has introduced a new educational resource for healthcare professionals designed to curb the abuse of prescription drugs, the company said Monday.

May 4, 2012

Kmart is introducing prescription pet medications at its stores, the mass merchandise retail chain said Friday.

HOFFMAN ESTATES, Ill. — Kmart is introducing prescription pet medications at its stores, the mass merchandise retail chain said Friday.

The company said the new program was designed to make it easier for customers to get branded and generic pet drugs and more convenient to shop for the whole family. More than 60% of American households own a pet, and families spent more than $50 billion on their pets in 2011, according to the American Pet Products Association.